Clinical Center; Notice of Closed Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

February 21, 2024

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 35 (Wednesday, February 21, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 35 (Wednesday, February 21, 2024)]
[Notices]
[Pages 13087-13088]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-03441]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Clinical Center; Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors of the NIH Clinical Center.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended, for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the Clinical 
Center, including consideration of personnel qualifications and 
performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors of the NIH 
Clinical Center.
    Date: March 25, 2024.
    Time: 11:00 a.m. to 5:00 p.m.

[[Page 13088]]

    Agenda: To review and evaluate the Pediatrics and Critical Care 
Medicine Department, Emerging Pathogens Section.
    Place: Clinical Center, 10 Center Drive, Bethesda, MD 20892 
(Virtual).

    Name of Committee: Board of Scientific Counselors of the NIH 
Clinical Center.
    Date: March 26, 2024.
    Time: 11:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate the Pediatrics and Critical Care 
Medicine Department, Emerging Pathogens Section.
    Place: Clinical Center, 10 Center Drive, Bethesda, MD 20892 
(Virtual).
    Contact Person: Ronald Neumann, M.D., Deputy Scientific 
Director, Clinical Center, National Institutes of Health, 10 Center 
Drive, Bethesda, MD 20892, 301-496-6455, <a href="/cdn-cgi/l/email-protection#dfadb1baaab2beb1b19fbcbcf1b1b6b7f1b8b0a9"><span class="__cf_email__" data-cfemail="9eecf0fbebf3fff0f0defdfdb0f0f7f6b0f9f1e8">[email&#160;protected]</span></a>.

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.

Patricia B. Hansberger,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03441 Filed 2-20-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on February 21, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.